NEWS 76 FEED & ADDITIVE MAGAZINE January 2025 The Cultured Hub, the joint venture of the Swiss companies Givaudan, Migros, and Bühler, officially opened its doors, marking a milestone for the global cellular agriculture and food industry communities. The pioneering scale-up and growth service aims to revolutionize the cultivated food and beverage sector by accelerating the development and market penetration of cellular agriculture products. These innovations can address increasingly complex food system challenges, reducing environmental impact and improving food security, the companies explained. Equipped with advanced product development labs, cell culture, and fermentation capabilities and equipment, and with its ecosystem of partners, the hub is designed to empower start-ups and organizations to scale up and accelerate the development of market-ready, sustainable, healthy, and affordable products. The hub offers a technology platform that extends beyond food and can support the development of diverse products, such as meat, fish, dairy, pet food, and plantbased cells like cocoa – as well as materials like cosmetics and selective pharma applications. "The launch of The Cultured Hub is a pivotal moment in the global push for sustainable food production," said Yannick Gaechter, CEO of The Cultured Hub. "The opening of this facility is not just an achievement for our team, but a landmark moment for the industry. We are excited to open a facility that will enable start-ups to scale up without heavy capital investment and contribute to global food system improvements.” Read more>> The Cultured Hub opens its doors Poland-based Proteon Pharmaceuticals announced that the Ministry of Agriculture, Livestock Farming and Supplies (MAPA) in Brazil registered BAFASAL PRO, the company’s latest bacteriophage-based feed additive. BAFASAL PRO harnesses the power of natural bacteriophage technology to improve animal health and production efficiency, Proteon explained. As Proteon’s CEO highlighted, this registration underscores the company’s commitment to providing effective and natural solutions to address global food production challenges. Brazil, the world’s second-largest producer of chicken meat, represents a significant milestone in its efforts to broaden access to bacteriophage technology on a global scale. “The successful registration of BAFASAL PRO marks our third product approval in Brazil and the second in 2024, validating our strategic approach and the market’s confidence in our solutions. This continued expansion of our product portfolio in one of the world’s leading agricultural markets reflects the increasing demand for our innovative technologies. This expansion confirms our commitment to advancing global healthcare solutions and our dedication to growth in international markets,” expressed Professor Jarosław Dastych, Founder & CEO of Proteon Pharmaceuticals. Read more>> Proteon's bacteriophage-based feed additive approved in Brazil
RkJQdWJsaXNoZXIy MTUxNjkxNQ==